This
Amendment to the Tender Offer Statement on Schedule TO (this “Amendment”) amends and supplements the Tender Offer Statement on Schedule TO filed with the U.S. Securities and Exchange Commission (the “SEC”) on April 9, 2023 (as amended, the “Schedule TO”), by Cresco Labs Inc., a corporation organized under the laws of the Province of British Columbia (the “Company”), relating to the offer by the Company to certain optionholders to exchange certain outstanding options to purchase the Company’s subordinate voting shares for new options to purchase the Company’s subordinate voting shares. This Amendment is made solely to amend and supplement Item 12 of the Schedule TO as more specifically described below. The information in the Schedule TO, including all schedules and annexes to the Schedule TO that were previously filed with the Schedule TO, is
incorporated herein by reference to answer the items required in this Amendment. Except as specifically set forth herein, this Amendment does not modify any of the information previously reported on the Schedule TO. You should read this Amendment together with the Schedule TO.
ITEM 12. Exhibits.
Item 12 of the Schedule TO is amended and supplemented by (i) replacing the Presentation and Accompanying Script for Presentation filed as Exhibits (a)(1)(G) and (a)(1)(H), respectively, with updated versions of those documents, (ii) adding a hyperlink to the filing
incorporated by reference in Exhibit (d)(1), and (iii) adding Exhibit 107 which was inadvertently omitted with the initial filing.
After due inquiry and to the best of my knowledge and belief, I certify that the information set forth
in this statement is true, complete and correct.
